| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 01/08/2004 | US20040006137 Asymmetric synthesis of amino-pyrrolidinones and a crystalline, free-base amino-pyrrolidinone |
| 01/08/2004 | US20040006103 Use of chloroquine, hydroxychloroquine and 4 amino-quinolinic derivatives to obtain a drug for the anti retroviral therapy, active towards HIV sensitive strains and towards HIV strains which are resistant to both nucleosidic and non-nucleosidic reverse transcriptase inhibitors and to proteases inhibitors |
| 01/08/2004 | US20040006102 Alkoxy aryl beta2 adrenergic receptor agonists |
| 01/08/2004 | CA2493854A1 Phosphodiesterase inhibitor |
| 01/08/2004 | CA2489560A1 Substituted quinoline ccr5 receptor antagonists |
| 01/08/2004 | CA2489433A1 Inhibitors of hcv ns5b polymerase |
| 01/07/2004 | EP1377567A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 01/07/2004 | EP1377555A1 Novel compounds |
| 01/07/2004 | EP1377554A1 Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases |
| 01/07/2004 | EP1377553A1 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof |
| 01/07/2004 | EP1377550A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
| 01/07/2004 | EP1377283A2 Compounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 01/07/2004 | EP1175417B1 Substituted benzolactam compounds |
| 01/07/2004 | EP1056733B1 Histamine h3 receptor ligands |
| 01/07/2004 | CN1466575A Quinolene derivatives as anti-inflammation agents |
| 01/07/2004 | CN1133432C Aqueous liquid preparations |
| 01/06/2004 | US6673801 Dihydroxyhexanoic acid derivatives |
| 01/02/2004 | EP1375487A1 Process for producing quinoline-3-carboxylic acid compound |
| 01/02/2004 | EP1375486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 01/02/2004 | EP1375485A1 Method for preparing 7-quinolinyl-3,5-dihydroxyhept-6-enoate |
| 01/02/2004 | EP1374867A1 Use of chloroquine, hydroxychloroquine and 4 amino-quinolinic derivatives to obtain a drug for the anti retroviral therapy, active towards hiv sensitive strains and towards hiv strains which are resistant to both nucleosidic and non-nucleosidic reverse transcriptase inhibitors and to proteases inhibitors |
| 01/02/2004 | EP1373240A2 Retinoid x receptor modulators |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373211A1 Quinoline derivatives and their use as antibiotics |
| 01/02/2004 | EP1373192A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1372655A2 Cathepsin cysteine protease inhibitors |
| 01/02/2004 | EP1372654A2 Quinoline inhibitors of hyak1 and hyak3 kinases |
| 01/02/2004 | EP1044187B1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia |
| 01/01/2004 | US20040002604 Phenylalkynes |
| 01/01/2004 | US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device |
| 01/01/2004 | US20040002506 Antiproliferative agents; antitumor agents |
| 01/01/2004 | US20040002493 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient |
| 01/01/2004 | US20040002123 Detection of transmembrane potentials by optical methods |
| 01/01/2004 | US20040001970 Organic electroluminescent materials and devices made from such materials |
| 12/31/2003 | WO2004000828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| 12/31/2003 | WO2004000814A1 8-(biaryl) quinoline pde4 inhibitors |
| 12/31/2003 | WO2004000797A1 Alpha-sulfonylamino-acetonitriles |
| 12/31/2003 | CN1132818C 用作抗病毒剂的4－氧代－1,4－二氢－3－喹啉甲酰胺 As antiviral agents 4-oxo-1,4-dihydro-3-quinoline carboxamide |
| 12/31/2003 | CA2490043A1 8-(biaryl) quinoline pde4 inhibitors |
| 12/31/2003 | CA2486989A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| 12/30/2003 | US6670645 Bright, efficient, stable; increased volatility for lower temperature vacuum deposition preventing decomposition |
| 12/30/2003 | US6670377 Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof |
| 12/30/2003 | US6670376 Aryl aniline β2 adrenergic receptor agonists |
| 12/29/2003 | CA2433983A1 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 12/28/2003 | CA2433237A1 Use of chloroquine, hydroxy chloroquine and 4 amino-quinolinic derivatives to obtain a drug for the anti retroviral therapy, active towards hiv sensitive strains and towards hiv strains which are resistant to both nucleosidic and nonnucleosidic reverse transcriptase inhibitors and to proteases inhibitors |
| 12/25/2003 | WO2003106424A1 Process for the manufacture of quinoline derivatives |
| 12/25/2003 | US20030236281 Quinoline derivatives(2) |
| 12/25/2003 | US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor |
| 12/25/2003 | US20030236259 Novel aryl- and heteroarylpiperazines |
| 12/24/2003 | WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 12/24/2003 | WO2003106423A1 Cyclic amine and medicinal composition containing the same |
| 12/24/2003 | WO2003106422A1 BLUE EMITTING TRIS (8-OXOQUINOLINE) ALUMINUM (III) (AlQ3) |
| 12/24/2003 | WO2003106421A2 Phenylalkylamines and pyridylalkylamines |
| 12/24/2003 | WO2003106390A1 Polymerisation inhibitor |
| 12/24/2003 | WO2003105851A1 Novel crystalline forms of gatifloxacin |
| 12/24/2003 | WO2003105850A1 2-aminoquinolines as melanin concentrating hormone receptor antagonists |
| 12/24/2003 | WO2003105849A1 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 12/24/2003 | WO2003074025A3 Pressurised metered dose inhalers containing solutions of beta-2 agonists |
| 12/24/2003 | WO2003068760A3 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 12/24/2003 | WO2003039454A3 Beta-secretase inhibitors and methods of use |
| 12/24/2003 | CN1463191A Low hygroscopic aripiprazole drug substance and processes for prepn. thereof |
| 12/24/2003 | CA2489377A1 Novel crystalline forms of gatifloxacin |
| 12/24/2003 | CA2488407A1 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 12/23/2003 | US6667307 HIV protease |
| 12/18/2003 | WO2003104221A1 Inhibitors of the gpib -vwf interaction, their preparation and use |
| 12/18/2003 | WO2003104195A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans |
| 12/18/2003 | WO2003103671A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 12/18/2003 | WO2003103668A1 Pyridin-2-one and quinolin-2-one derivatives, preparation thereof and use thereof as antibacterials |
| 12/18/2003 | US20030233001 Process for the manufacture of organic compounds |
| 12/18/2003 | US20030232990 For therapy of arteriosclerosis and dyslipidaemias |
| 12/18/2003 | US20030232989 Process for the preparation of specific aromatic aldehydes |
| 12/18/2003 | US20030232868 Cyclic carboxylic acids as integrin antagonists |
| 12/18/2003 | US20030232863 Cathepsin cysteine protease inhibitors |
| 12/18/2003 | US20030232859 Antiinflammatory agents; for treatment of rheumatoid arthritis and multiple sclerosis |
| 12/18/2003 | US20030232854 Such as 3-methyl-5-(2-chloro-6-fluorophenyl)-4-isoxazole-carboxylic acid ethyl ester for inhibiting multidrug resistance protein (MRP1) |
| 12/18/2003 | US20030232846 Caspase inhibitors and uses thereof |
| 12/18/2003 | US20030232844 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2 mediated disorders |
| 12/18/2003 | US20030232808 Sulfonyl derivatives |
| 12/18/2003 | US20030232807 Dietetic agents |
| 12/18/2003 | US20030232802 Aryl and heteroaryl sulfonates |
| 12/18/2003 | US20030232801 Identification of compounds for the treatment or prevention of proliferative diseases |
| 12/18/2003 | US20030232792 Useful for male contraception, treatment of a variety of hormone-related conditions such as sexual disorders, prostate cancer |
| 12/18/2003 | DE10215316C1 Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer Quinoline and isoquinoline derivatives, to a pharmaceutical agent and their use as anti-inflammatory agents |
| 12/18/2003 | CA2488193A1 Inhibitors of the gpib -vwf interaction, their preparation and use |
| 12/18/2003 | CA2486491A1 4-(aryl or heteroaryl)-2-butylamine derivatives and their use as glucocorticoid ligans |
| 12/17/2003 | EP1370532A1 Method for producing cyclopentadiene compounds |
| 12/17/2003 | EP0934276B1 Anthranilic acid derivatives as multi drug resistance modulators |
| 12/17/2003 | CN1462273A Bicyclic heteroaromatic compounds |
| 12/17/2003 | CN1461748A Synthesis process of jiatisasin |
| 12/17/2003 | CN1131214C Tetrahy droquimoline derivatives as EAA antagonists |
| 12/17/2003 | CN1131213C Carbostyril derivatives as antithrombotic agents |
| 12/17/2003 | CN1131211C Heteraryl diazacy cloa lkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 12/17/2003 | CN1131202C Calcium receptor-active compounds |
| 12/16/2003 | US6664393 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 12/16/2003 | CA2269547C Process for converting nitrogen-containing hydroxy heteroaromatics to arylamines |
| 12/11/2003 | WO2003101941A2 Alpha acyloxyacetamides for kallikrein and urokinase inhibition |
| 12/11/2003 | WO2003101442A1 Peptide deformylase inhibitors |
| 12/11/2003 | WO2003064382A3 Process for the manufacture of organic compounds |
| 12/11/2003 | WO2003024395A3 Linked biaryl compounds |